<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03790644</url>
  </required_header>
  <id_info>
    <org_study_id>XO-Nof1-RCT-RG2019</org_study_id>
    <nct_id>NCT03790644</nct_id>
  </id_info>
  <brief_title>Powered Assist to Improve Ambulation in Severe Lung Disease</brief_title>
  <acronym>REVIVE</acronym>
  <official_title>Assistive Device to Improve Physical Performance in Patients With Very Severe Chronic Respiratory Disease - Evaluated Using a Single-Case Series Experimental Design</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West Park Healthcare Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West Park Healthcare Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic respiratory disease (CRD) is among the most prevalent and growing diseases worldwide&#xD;
      with disabling consequences. Many with a compromised respiratory system cannot support the&#xD;
      metabolic energy demands of walking causing them to walk slowly and stop often. Those with&#xD;
      CRD could receive substantial benefit from a powered wearable exoskeleton device that assumes&#xD;
      part of the energy of walking. Assisting the legs will lower the metabolic energy demands,&#xD;
      and therefore the ventilation required for exercise, thereby allowing them to walk faster and&#xD;
      further. Proposed is a series of single-case experiments comparing walking endurance with and&#xD;
      without a powered exoskeleton assist. The aim of this study is to determine the efficacy of&#xD;
      an exoskeleton on walking endurance in ventilatory limited patients with CRD. An exoskeleton&#xD;
      could be a novel immediate and long term strategy to augment walking as part of the spectrum&#xD;
      of pulmonary rehabilitation and community reintegration.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Actual">May 30, 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>A prospective longitudinal, self-controlled, single-case repeated measures alternating treatment, randomized and counterbalanced cross-over experimental trial design, comparing walking endurance without and with a powered exoskeleton.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>walking endurance time</measure>
    <time_frame>an average of 7 tests over 4 weeks</time_frame>
    <description>tolerance (time) of an individualized constant, brisk, walking speed endurance test</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Lung Disease Chronic</condition>
  <arm_group>
    <arm_group_label>exoskeleton assist</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>walking with assist of a powered exoskeleton</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>exoskeleton assist</intervention_name>
    <description>A powered exoskeleton describes a wearable robot designed around the shape and function of the human body with segments and joints externally coupled to those of the user. The exoskeleton includes a rigid outer frame, sensors that detect a user's desired movements, a computerized controller, motors and actuators, and lightweight batteries.&#xD;
The exoskeleton is designed to be worn in the community.</description>
    <arm_group_label>exoskeleton assist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  stable chronic respiratory disease&#xD;
&#xD;
          -  modified medical research council dyspnoea score (mMRC) â‰¥ 2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  evidence of cardiac rhythm or circulatory compromise&#xD;
&#xD;
          -  myocardial infarct within the previous three months&#xD;
&#xD;
          -  moderate-severe aortic stenosis&#xD;
&#xD;
          -  uncontrolled hypertension&#xD;
&#xD;
          -  sustained cardiac arrhythmias&#xD;
&#xD;
          -  untreated neoplasia&#xD;
&#xD;
          -  lung surgery within the previous three months&#xD;
&#xD;
          -  any other predominant co-morbidities or treatments that might influence walk testing&#xD;
&#xD;
          -  body size outside of exoskeleton fit specifications&#xD;
&#xD;
          -  skin sores or skin breakdown in the area where the device is worn&#xD;
&#xD;
          -  a high risk of fracture&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roger S Goldstein</last_name>
    <role>Principal Investigator</role>
    <affiliation>West Park Healthcare Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Westpark Health Care Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6M 2J5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 20, 2018</study_first_submitted>
  <study_first_submitted_qc>December 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 31, 2018</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West Park Healthcare Centre</investigator_affiliation>
    <investigator_full_name>Roger Goldstein</investigator_full_name>
    <investigator_title>Director, Program in Respiratory Rehabilitation</investigator_title>
  </responsible_party>
  <keyword>Walking</keyword>
  <keyword>Exoskeleton Device</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data (IPD) will not be available to other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

